MedTrace Logo

CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma

NCT06095154 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 474

Last updated 2025-03-13

No results posted yet for this study

Summary

This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. The aim of this study is to evaluate the efficacy and safety of modified IMRT, of which CTV delineation was only based on geometric expansion from GTV.

Conditions

  • Nasopharyngeal Carcinoma by AJCC V8 Stage

Interventions

RADIATION

CTV Delineation Based on Geometric Expansion From GTV in Nasopharyngeal Carcinoma

CTVp2 is generated by expanding GTVp by 10 mm and including the nasopharyngeal mucosa.

Sponsors & Collaborators

  • Fujian Cancer Hospital

    lead OTHER_GOV

Principal Investigators

  • Shaojun Lin, DR · Fujian Cancer Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2027-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06095154 on ClinicalTrials.gov